Clinical Trials Browser

Carcinoma, Transitional Cell × cabazitaxel × 30 days × Clear all

NCT01616875 2026-03-06

Bristol Bladder Trial

Phase 2 Completed

28 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell